Plasma Homocysteine Levels and Different Forms of Vascular Disease in Patients with Dementia and Other Psychogeriatric Diseases

被引:7
作者
Nilsson, Karin [1 ]
Gustafson, Lars [1 ]
Hultberg, Bjorn [2 ]
机构
[1] Univ Lund Hosp, Dept Psychogeriatr & Clin Sci, S-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Clin Chem & Lab Med, S-22185 Lund, Sweden
基金
英国医学研究理事会;
关键词
Cobalamin; Creatinine; Folate; Homocysteine; Psychogeriatric patients; Vascular disease; CORONARY-HEART-DISEASE; MILD COGNITIVE IMPAIRMENT; POSSIBLE RISK FACTOR; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; ISCHEMIC-STROKE; FOLIC-ACID; CEREBROVASCULAR-DISEASE; ALZHEIMER-DISEASE; B-VITAMINS;
D O I
10.1159/000193628
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
Background: Total plasma homocysteine (tHcy) concentration is elevated in patients with psychogeriatric disease. There are many different determinants of plasma tHcy concentration, including the presence of vascular disease. Method: We investigated plasma tHcy levels in several different subgroups of vascular disease and also the relation between plasma tHcy and renal function in patients with psychogeriatric disease. Results: All different groups of patients with vascular disease exhibited an elevated level of plasma tHcy compared to patients without vascular disease even after exclusion of patients with folate/cobalamin deficiency. Patients with elevated serum creatinine with or without vascular disease exhibited significantly increased plasma tHcy compared to the respective groups of patients without elevated serum creatinine. Patients with vascular dementia and Alzheimer's disease with concomitant vascular disease exhibited significantly increased plasma tHcy levels compared to patients without vascular disease. Conclusion: The presence of vascular disease increases the level of plasma tHcy and renal impairment further increases the elevated plasma tHcy level. Furthermore, the findings suggest similar influence on plasma tHcy turnover irrespective of whether the vascular disease is of cerebral or extracerebral origin or only manifests itself as arrhythmia or hypertension. Copyright (c) 2009 S. Karger AG, Basel
引用
收藏
页码:88 / 95
页数:8
相关论文
共 59 条
[1]
Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline? [J].
Alagiakrishnan, K ;
McCracken, P ;
Feldman, H .
POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (964) :101-105
[2]
RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].
ALFTHAN, G ;
PEKKANEN, J ;
JAUHIAINEN, M ;
PITKANIEMI, J ;
KARVONEN, M ;
TUOMILEHTO, J ;
SALONEN, JT ;
EHNHOLM, C .
ATHEROSCLEROSIS, 1994, 106 (01) :9-19
[3]
ANDERSSON A, 1993, CLIN CHEM, V39, P1590
[4]
[Anonymous], 1994, DSM 4
[5]
HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[6]
Homocysteine lowering and cardiovascular events after acute myocardial infarction [J].
Bonaa, KH ;
Njolstad, I ;
Ueland, PM ;
Schirmer, H ;
Tverdal, A ;
Steigen, T ;
Wang, H ;
Nordrehaug, JE ;
Arnesen, E ;
Rasmussen, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) :1578-1588
[7]
Bottiglieri T, 1996, NUTR REV, V54, P382, DOI 10.1111/j.1753-4887.1996.tb03851.x
[8]
Brattstrom L, 1997, CIRCULATION, V96, P3805
[9]
MODERATE HOMOCYSTEINEMIA - A POSSIBLE RISK FACTOR FOR ARTERIOSCLEROTIC CEREBROVASCULAR-DISEASE [J].
BRATTSTROM, LE ;
HARDEBO, JE ;
HULTBERG, BL .
STROKE, 1984, 15 (06) :1012-1016
[10]
Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5